|
Thursday, 26 November 2009 10:22 |
IAEA Publication
This publication presents a summary of discussions from a consultants meeting on the merits and challenges associated with the operation of aqueous homogenous reactors (AHRs) for the production of the isotope technetium-99m (99mTc) and includes the technical presentations given by the participants during the meeting. Currently, 80% of all radiopharmaceutical procedures employ 99mTc, a product of the decay of the isotope 99Mo. It is normally obtained through the fission of highly enriched uranium (HEU), but research has shown that the use of AHRs offers an attractive alternative to the conventional target irradiation method of producing 99Mo. The elimination of the need for targets allows the reactor to run at much lower power and therefore holds interest for companies developing innovative solutions to satisfy increasing demands for medical isotopes.
IAEA TECDOC Series No. 1601 Date of Issue: 15 December 2008.
Link
|
|
Tuesday, 24 November 2009 12:54 |
|
Link to article |
|
Tuesday, 08 September 2009 10:41 |
Boise, Idaho, September 8, 2009 – Alternate Energy Holdings, Inc. (OTC: AEHI.PK): A critical worldwide shortage of nuclear isotopes has forced doctors to forgo lifesaving tests and increased testing cost– underscoring the need for more nuclear reactors, according to AEHI proposing to build a nuclear plant in Idaho.
Read more: pinnacledigest.com |
Link to website
GE global manufacturing failure 